Atlas Trials

European Myeloma Network B.V.

18 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch European Myeloma Network B.V.

RecordFirmDate
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant (NCT06932562)European Myeloma Network B.V.2025-12-23
Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab. (NCT07107529)European Myeloma Network B.V.2025-12-12
A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis (NCT06649695)European Myeloma Network B.V.2025-07-02
European Myeloma Network (EMN) Sample Project (NCT06237803)European Myeloma Network B.V.2022-12-21
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation (NCT05243797)European Myeloma Network B.V.2022-09-08
Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL) (NCT04483739)European Myeloma Network B.V.2020-09-25
A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe (NCT04937777)European Myeloma Network B.V.2019-04-23
Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-Dara (NCT03896737)European Myeloma Network B.V.2019-04-16

Track European Myeloma Network B.V. automatically

Every clearance here is in the API, with alerts when new ones post.